Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes

We have previously shown that extracellular ATP, like norepinephrine (NE) and many other hypertrophy-inducing agents, increases expression of the immediate-early genes c-fos and junB in cultured neonatal cardiac myocytes but that the intracellular signaling pathways activated by ATP and responsible for these changes differ from those stimulated by NE. Furthermore, whereas NE increases incorporation of [14C]phenylalanine (14C-Phe) and cell size in neonatal cardiomyocytes, ATP does not. Since ATP is coreleased with NE from sympathetic nerve endings in the heart, we investigated whether ATP could modulate cardiac hypertrophy induced by adrenergic agonists, such as NE. We report in the present study that extracellular ATP inhibited the increase in incorporation of 14C-Phe into cellular protein and the increase in cell size in neonatal rat cardiac myocytes that was induced by NE, phenylephrine (PE), basic fibroblast growth factor, or endothelin-1. This inhibition was dose dependent, occurred predominantly through P2 purinergic receptors, and was observed even when cells were treated with ATP for as little as 1 hour before the addition of the hypertrophy-inducing agent. ATP also selectively affected changes in gene expression associated with hypertrophy. It prevented PE-stimulated increases in atrial natriuretic factor and myosin light chain-2 mRNA levels, while appearing to augment basal and PE-stimulated skeletal alpha-actin mRNA levels. ATP alone increased sarcoplasmic reticulum Ca2+-ATPase mRNA levels but had no effect when added with PE. ATP did not significantly affect the level of the constitutively expressed mRNA for GAPDH. Neither the PE-stimulated increase in immediate-early gene expression nor the initial induction of mitogen-activated protein kinase activity by PE was inhibited by ATP. These results demonstrate that extracellular ATP can inhibit hypertrophic growth of neonatal cardiac myocytes and differentially alter the changes in gene expression that accompany hypertrophy.

Effect of interferon-gamma on antigen-induced eosinophil infiltration into the mouse airway

OBJECTIVE

To investigate whether murine recombinant interferon-gamma (IFN-gamma) is capable of inhibiting antigen-induced eosinophil (EOS) infiltration into the mouse airway.

MATERIALS AND METHODS

BALB/c mice were sensitized and challenged repeatedly with ovalbumin (OVA) to develop an allergic airway inflammation model. The experimental mice were given injection of different doses of IFN-gamma. The numbers of EOS in bronchoalveolar lavage fluid (BALF) from each group were counted, and concentrations of interleukin (IL)-5 in supernatants of cultured spleen cells were detected.

RESULTS

In sensitized mice challenged with OVA 20 minutes once a day for 6 days, the number of BLAF EOS was 9.53 +/- 0.84 x 10(5)/ml. However, no EOS could be found in BALF from mice without OVA sensitization and challenge. In mice treated with IFN-gamma, doses of IFN-gamma (1.0 x 10(3), 1.0 x 10(4), 1.0 x 10(5)U/KG) produced 29.8% (P < 0.05), 55.7% (P < 0.01), and 69.0% (P < 0.01) inhibition of eosinophilia, respectively. The results also showed that IFN-gamma prevented antigen-induced EOS recruitment into airway accompanied be decrement of levels of IL-5 with a dose-related response.

CONCLUSION

IFN-gamma is capable of inhibiting EOS infiltration into mouse airway by inhibiting the production of IL-5. Our results suggested that IFN-gamma may be of value in treating asthma in human beings.

Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart

Chronic infusion of isoproterenol (Iso) in rats results in cardiac hypertrophy via incompletely understood mechanisms. Our purpose was to determine whether Iso infusion would alter the expression of genes associated with hypertrophy. Male Wistar rats received either 2.4 mg Iso.kg-1.day-1, 9.9 mg propranolol (Prop).kg-1.day-1, both Iso and Prop, or vehicle (NaCl) via subcutaneously implanted osmotic pumps. In Iso-treated rats, the ventricular weight-to-body weight ratio was increased by 27% after 1 day and peaked on day 3 (+ 40%). Levels of atrial natriuretic factor (ANF) and fibronectin (FN) mRNA in the left ventricles were elevated 20-fold and 13-fold in Iso-treated rats, respectively, peaking at 3 days of infusion. The increase in FN mRNA accumulation was at least partially accounted for by elevated expression of extra type IIIA and IIIB (EIIIA and EIIIB) splicing variants. Levels of transforming growth factor (TGF)-beta 1 mRNA were elevated twofold after 3 days of Iso infusion. The abundance of skeletal alpha-actin (SK) mRNA increased fourfold after 1 day of Iso and declined thereafter. Iso infusion decreased sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) and preproenkephalin (PNK) gene expression by approximately 50% and induced a myosin heavy chain (MHC) isogene switch favoring beta-MHC. Prop partially inhibited the Iso-evoked increases in ANF and FN mRNA, completely prevented the Iso-induced changes in TGF-beta 1 and SERCA mRNA, but had no effect on the Iso-stimulated changes in SK and PNK gene expression. These results demonstrate that chronic Iso infusion elicits alterations in cardiac gene expression that are consistent with the development of myocyte hypertrophy and interstitial fibrosis and are directionally identical to those previously reported for pressure overload hypertrophy.

Helicobacter pylori-associated gastritis and gastric carcinoma in Beijing

A retrospective study was performed on 500 consecutive gastric biopsies obtained from patients with a diagnosis of gastritis and gastric carcinoma. Overall, Helicobacter pylori was detected in 336 cases (67.2%); it was seen in 82.4% of patients with duodenal ulcer, 80.1% of patients with gastric ulcer, 76.1% of patients with chronic atrophic gastritis, 60.3% of patients with chronic superficial gastritis, and 32.1% of patients with gastric carcinoma. The gastric epithelium colonized by Helicobacter pylori showed characteristic changes including loss of the apical mucous portion of individual cells, dropout of epithelial cells, and erosions. There is a strong suggestion that the inflammation associated with Helicobacter pylori infection plays a role in the pathogenesis of gastric carcinoma.

[Antifatigue and anoxia-tolerating effects of the root of Tragopogon porrifolius L]

The root of Tragopogon porrifolius can evidently prolong the duration of swimming and stick-climbing for mice. The drug has provided food for tolerating anoxia in several models of rats and mice.